Nexalin Technology NXL
NASDAQ NXL
$0.33 +0.00 (+0.03%)
At close: Aug 20, 2026 · 12:43 PM UTC

Nexalin Technology (NXL) EPS (Diluted) Growth (3y) (2025 - 2026)

Nexalin Technology (NXL) EPS (Diluted) Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) Growth (3y) (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn -12.16%
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn 19.81%
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn 3.09%
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn 50.83%
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn -6.12%
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn 33.46%
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn 11.48%
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 1,810.75%
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn 18.07%
10 Nexalin Technology 6.98 Mn 5.97 Mn 8,897.00 2.10%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.03%
Mar 31, 2026 -0.99%
Dec 31, 2025 -2.12%
Sep 30, 2025 -29.77%
Jun 30, 2025 -3.05%